Cite
MLA Citation
K. Papp et al.. “SAT0287 Long-Term Safety Of Ustekinumab: 5 Years of Follow-Up from the Psoriasis Clinical Development Program Including Patients with Psoriatic Arthritis.” Annals of the rheumatic diseases, vol. 72, 2013, p. A680. http://access.bl.uk/ark:/81055/vdc_100135556763.0x000061